Evidence map›Paper›PMID 42340848›Full record

ArticleSTAR protocols2026

Protocol for enhancing production of human PSC-derived cardiomyocytes and endothelial cells with placental growth factor.

Liang Liu, Phuong Thao Nguyen, Jie Liu, Makoto Sahara

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liang LiuDepartment of Regenerative Medicine, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka 431-3192, Japan. Electronic address: liuliang@hama-med.ac.jp.
Phuong Thao NguyenDepartment of Regenerative Medicine, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka 431-3192, Japan.
Jie LiuDepartment of Regenerative Medicine, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka 431-3192, Japan.
Makoto SaharaDepartment of Regenerative Medicine, Hamamatsu University School of Medicine, Hamamatsu City, Shizuoka 431-3192, Japan. Electronic address: maksahara@hama-med.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Placental growth factor (PLGF) drives cardiomyogenesis and vasculogenesis during cardiogenesis. Here, we present a protocol for enhancing production of human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) and endothelial cells (ECs). We describe steps for CM-/EC-directed hPSC differentiation with PLGF. Our approaches can achieve production of hPSC-CMs/-ECs by 2- to 2.5-fold compared with those in traditionally established protocols, through promoting proliferation and differentiation of cardiac and vascular progenitors. For complete details on the use and execution of this protocol, please refer to Witman et al.

Indexed as

Cell cultureCell DifferentiationDevelopmental biologySingle CellStem Cells

Identifiers

PMID42340848
PMCPMC13316504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.